Pharma News, 2018

Celgene, the acquisitive drugmaker, is in talks with Juno Therapeutics about buying the developer of cutting-edge cancer treatments in what would be its second big deal of 2018.

PALO ALTO, CA, USA I January 16, 2018 I Eiger BioPharmaceuticals, Inc.

FRANKFURT (Reuters) - German generic drugs company Stada (STAGn.

A phase I clinical trial to explore the safety of a new class of drug to treat attention-deficit hyperactivity disorder (ADHD) is published this week in Nature Communications.

For anyone who has accidentally injured themselves, Dr.

Pfizer subsidiary Greenstone has introduced its authorized generic of Silvadene Cream (silver sulfadiazine cream, 1%).

Mumbai-based Sun Pharma has settled its litigation with Allergan and Ironwood Pharmaceuticals.

The Food and Drug Administration recently approved Aurobindo’s generic of Mylan’s Arixtra (fondaparinux sodium) injection.

Roche is set to announce its full-year results and expectations for 2018 on Feb.

The US Patent and Trademark Office has rejected a petition filed in July last year by Concert Pharmaceuticals challenging a patent awarded to Incyte Pharmaceuticals.

Japanese pharma major Eisai says its Chinese subsidiary, Eisai China Inc (ECI) has completed construction of a new oral solid dose (OSD) production facility and an administration build...

FRANKFURT (Reuters) - German drugmaker Dermapharm is preparing for an initial public offering (IPO), probably stealing a march on much larger Siemens’ healthcare unit Healthineers as...